Wardah Rafaqat, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Abdominal Cavity | 2 | 2024 | 52 | 1.830 |
Why?
|
| Peritoneal Lavage | 1 | 2023 | 35 | 0.940 |
Why?
|
| Negative-Pressure Wound Therapy | 1 | 2023 | 150 | 0.800 |
Why?
|
| Laparotomy | 1 | 2023 | 473 | 0.780 |
Why?
|
| Infertility, Male | 2 | 2022 | 409 | 0.750 |
Why?
|
| Urinary Tract Infections | 2 | 2023 | 788 | 0.750 |
Why?
|
| Abdominal Injuries | 1 | 2023 | 352 | 0.740 |
Why?
|
| Inhibins | 1 | 2020 | 211 | 0.710 |
Why?
|
| Communicable Diseases | 2 | 2023 | 880 | 0.630 |
Why?
|
| Rib Fractures | 3 | 2023 | 131 | 0.610 |
Why?
|
| Surgical Wound Infection | 2 | 2023 | 1540 | 0.580 |
Why?
|
| Disabled Persons | 1 | 2023 | 1212 | 0.470 |
Why?
|
| Pakistan | 3 | 2023 | 295 | 0.440 |
Why?
|
| Spinal Fusion | 1 | 2022 | 1241 | 0.430 |
Why?
|
| Pneumonia | 1 | 2023 | 2133 | 0.400 |
Why?
|
| Sepsis | 1 | 2023 | 2593 | 0.340 |
Why?
|
| Palliative Care | 1 | 2023 | 3493 | 0.320 |
Why?
|
| HIV-1 | 1 | 2022 | 6939 | 0.240 |
Why?
|
| Contusions | 1 | 2023 | 81 | 0.220 |
Why?
|
| Peritoneum | 1 | 2023 | 228 | 0.210 |
Why?
|
| Thoracic Injuries | 1 | 2023 | 272 | 0.190 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2022 | 284 | 0.190 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2020 | 15520 | 0.190 |
Why?
|
| RNA Helicases | 1 | 2021 | 142 | 0.180 |
Why?
|
| Fecal Incontinence | 1 | 2023 | 239 | 0.180 |
Why?
|
| Hospitals | 2 | 2024 | 3954 | 0.180 |
Why?
|
| Cyclopropanes | 1 | 2021 | 416 | 0.180 |
Why?
|
| Carbamates | 1 | 2021 | 196 | 0.170 |
Why?
|
| Quinoxalines | 1 | 2021 | 290 | 0.170 |
Why?
|
| Drug Repositioning | 1 | 2021 | 230 | 0.170 |
Why?
|
| Lung Injury | 1 | 2023 | 436 | 0.160 |
Why?
|
| Urinary Incontinence | 1 | 2023 | 496 | 0.160 |
Why?
|
| Amides | 1 | 2021 | 459 | 0.160 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2022 | 880 | 0.160 |
Why?
|
| Retrospective Studies | 8 | 2023 | 77460 | 0.160 |
Why?
|
| Abdomen | 1 | 2024 | 1118 | 0.150 |
Why?
|
| Postoperative Complications | 4 | 2024 | 15297 | 0.150 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2023 | 795 | 0.150 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2023 | 687 | 0.150 |
Why?
|
| Syndrome | 1 | 2023 | 3252 | 0.140 |
Why?
|
| Iatrogenic Disease | 1 | 2020 | 547 | 0.140 |
Why?
|
| Humans | 22 | 2024 | 744366 | 0.140 |
Why?
|
| China | 1 | 2022 | 2245 | 0.140 |
Why?
|
| Heparin | 1 | 2023 | 1637 | 0.140 |
Why?
|
| HIV Infections | 1 | 2022 | 16715 | 0.130 |
Why?
|
| Case-Control Studies | 3 | 2023 | 21748 | 0.130 |
Why?
|
| Outpatients | 1 | 2023 | 1487 | 0.130 |
Why?
|
| Triazoles | 1 | 2021 | 908 | 0.130 |
Why?
|
| Phylogeny | 1 | 2022 | 2804 | 0.120 |
Why?
|
| Menopause | 1 | 2022 | 1626 | 0.120 |
Why?
|
| Neoplasms | 1 | 2023 | 21696 | 0.120 |
Why?
|
| Bayes Theorem | 1 | 2022 | 2307 | 0.120 |
Why?
|
| Patient Participation | 1 | 2023 | 1457 | 0.120 |
Why?
|
| Gene Frequency | 1 | 2020 | 3587 | 0.110 |
Why?
|
| Intraoperative Complications | 1 | 2020 | 1198 | 0.110 |
Why?
|
| General Surgery | 1 | 2023 | 1636 | 0.100 |
Why?
|
| Ribs | 2 | 2023 | 252 | 0.100 |
Why?
|
| Sulfonamides | 1 | 2021 | 1940 | 0.100 |
Why?
|
| Quality of Life | 2 | 2023 | 12802 | 0.100 |
Why?
|
| Vaccination | 1 | 2023 | 3279 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 1 | 2020 | 6171 | 0.090 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 1671 | 0.090 |
Why?
|
| Referral and Consultation | 1 | 2023 | 3531 | 0.090 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 3799 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 1 | 2020 | 5867 | 0.080 |
Why?
|
| Medicare | 2 | 2023 | 6566 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 4479 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2020 | 8319 | 0.070 |
Why?
|
| Wounds and Injuries | 1 | 2020 | 2400 | 0.070 |
Why?
|
| Genotype | 1 | 2020 | 12952 | 0.070 |
Why?
|
| Hospitalization | 1 | 2023 | 10259 | 0.060 |
Why?
|
| Adult | 5 | 2023 | 214052 | 0.050 |
Why?
|
| Neck Injuries | 1 | 2023 | 152 | 0.050 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2023 | 339 | 0.050 |
Why?
|
| Infant | 1 | 2023 | 35134 | 0.050 |
Why?
|
| Injury Severity Score | 1 | 2023 | 1014 | 0.050 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2020 | 40 | 0.050 |
Why?
|
| Length of Stay | 2 | 2023 | 6311 | 0.040 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2020 | 50 | 0.040 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2020 | 85 | 0.040 |
Why?
|
| United States | 2 | 2023 | 69872 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 17446 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 409 | 0.040 |
Why?
|
| Reimbursement, Incentive | 1 | 2023 | 540 | 0.040 |
Why?
|
| Atrophy | 1 | 2022 | 1584 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2022 | 53290 | 0.040 |
Why?
|
| Young Adult | 1 | 2023 | 56429 | 0.040 |
Why?
|
| Vagina | 1 | 2022 | 825 | 0.040 |
Why?
|
| Arteriovenous Fistula | 1 | 2020 | 315 | 0.040 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 250 | 0.030 |
Why?
|
| Pneumothorax | 1 | 2020 | 379 | 0.030 |
Why?
|
| Risk Factors | 1 | 2023 | 72296 | 0.030 |
Why?
|
| Male | 3 | 2023 | 350115 | 0.030 |
Why?
|
| Adolescent | 1 | 2023 | 85779 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2022 | 63107 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2023 | 1158 | 0.030 |
Why?
|
| Catheterization, Central Venous | 1 | 2020 | 514 | 0.030 |
Why?
|
| Aged | 2 | 2023 | 163288 | 0.030 |
Why?
|
| Viral Proteins | 1 | 2021 | 1900 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 2022 | 2055 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2022 | 4328 | 0.030 |
Why?
|
| Female | 3 | 2023 | 380193 | 0.020 |
Why?
|
| Middle Aged | 1 | 2023 | 213390 | 0.020 |
Why?
|
| Orthopedic Procedures | 1 | 2020 | 1289 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2021 | 2987 | 0.020 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 2002 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2023 | 4600 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2020 | 2150 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 2020 | 2375 | 0.020 |
Why?
|
| Catheter Ablation | 1 | 2020 | 2758 | 0.020 |
Why?
|
| Prevalence | 1 | 2023 | 15221 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2023 | 25039 | 0.010 |
Why?
|
| Child | 1 | 2023 | 77709 | 0.010 |
Why?
|